CardioComm Solutions (CVE:EKG) Sees 33.3% Rise – Should Investors Buy Now?

CardioComm Solutions, Inc. (CVE:EKG) experienced a significant increase of 33.3% in its stock price on Saturday. The shares reached a trading value as high as C$0.02, where they ultimately last traded. During midday trading, approximately 280,645 shares exchanged hands, representing a remarkable 321% increase compared to the average trading volume of 66,719 shares. The stock had previously closed at the same price of C$0.02.

CardioComm Solutions Trading Performance

The financials of CardioComm Solutions show a debt-to-equity ratio of 430.31, indicating a high level of debt relative to equity. The company's current ratio stands at 0.34 and the quick ratio at 0.24, both of which suggest potential liquidity concerns. With a market capitalization of C$3.86 million, the firm's price-to-earnings (PE) ratio is at 20.00. Additionally, the company has a beta of -0.15, reflecting relatively low volatility compared to the market. Its 50-day moving average price is C$0.01, with a 200-day moving average also at C$0.01.

About CardioComm Solutions

CardioComm Solutions, Inc. focuses on developing advanced software and hardware products, as well as providing core laboratory reading services related to electrocardiograms (ECG) and ambulatory arrhythmia monitoring systems. The company operates in both medical and consumer markets globally and is also involved in the sale of ECG recording equipment.

Further Insights

Investors may consider looking into several aspects before making a decision regarding CardioComm Solutions. Evaluating the company's financial health, its market strategies, and potential growth opportunities would be essential steps. Moreover, potential investors should also keep an eye on market trends and analysts' ratings regarding this stock.

CardioComm, Stock, Trading